TruthArchive.ai - Related Video Feed

In this video, the speaker addresses the current state of drug use for mental health problems, focusing on antidepressants, antipsychotics, and mood stabilizers. They challenge the belief that these medications correct an underlying chemical imbalance, arguing for a drug-centered model instead. The speaker discusses the historical development of the disease-centered model and the influence of pharmaceutical companies. They advocate for a more honest and collaborative approach to drug treatment. The issue of unpublished research and the addictive nature of psychotropic medications are also discussed. The importance of individuals taking control of their own health and seeking alternative treatments is emphasized. The Soteria project is mentioned as a potential alternative for treating psychosis without relying solely on medication. Additionally, the speakers highlight the significance of considering social factors in understanding mental health issues.

This video features a discussion among speakers regarding the analysis of adverse events in drug studies. The speakers criticize the FDA's approach of counting the number of participants who experience adverse events instead of the total number of events. They argue that both methods provide valuable information and that the FDA's approach may miss important data. The speakers also express concerns about the FDA's reliance on real-world data, which they believe is less reliable than clinical trial data. They highlight issues with the reporting system for adverse events and question the FDA's handling of serious adverse events related to COVID-19 vaccines. Overall, the video raises concerns about the FDA's approach to drug safety and calls for more rigorous evaluation of adverse events.

In the video, the speaker discusses additional deaths that occurred among people who received the Pfizer vaccine. They criticize Pfizer for not updating the slides or providing additional information about these deaths during the FDA meeting. The speaker believes that the FDA approval process failed because the panel did not ask about these deaths. They argue that if the data had been properly analyzed, it would have shown a higher cardiovascular risk with Pfizer compared to a placebo. The speaker concludes that Pfizer should not have been approved if all the data had been presented honestly and fairly.

In the video, the speaker discusses additional deaths that occurred among people who received the Pfizer vaccine. They criticize Pfizer for not updating the slides or providing additional information about these deaths during the FDA meeting. The speaker believes that the FDA approval process failed because the panel did not ask about these deaths. They argue that if the data had been properly analyzed, it would have shown a higher cardiovascular risk with Pfizer compared to a placebo. The speaker concludes that Pfizer should not have been approved if all the data had been presented honestly and fairly.

The psychiatric and drug industries have a financial interest in each other's success. Psychiatric drugs are widely consumed in America, with one in five people taking psychoactive drugs. These drugs have adverse effects, including an increased risk of suicide and violence. Despite this, there is little outrage in the government and medical community about the connection between psychiatric drugs and school shootings. When investigating the cause of these shootings, the coroner's office refused to release information about the drugs involved, citing privacy concerns. However, the argument that withholding this information protects public health is unfounded. It is likely that the suppression of information is driven by the financial interests of the psychiatric and drug industries.

The video discusses a study that found a 1,135% increased risk of autism in children who received a particular vaccine compared to those who didn't. The study was kept secret during a meeting attended by vaccine company heads and regulators. The video also mentions another study that looked at the connection between mercury vaccines and autism, finding a similar increased risk. The speaker argues that vaccines are a major cause of health issues in children, including autism. They criticize the CDC and FDA for covering up the evidence and highlight conflicts of interest in industry-funded studies. The speaker calls for more research and criticizes the media for not addressing the issue properly.

This video discusses the lack of safety studies and transparency in the vaccine industry. It highlights the conflicts of interest within government agencies and the pharmaceutical industry, as well as the lack of surveillance systems to monitor vaccine safety. The speaker emphasizes the need for a vaxxed versus unvaxxed study to compare the health outcomes of vaccinated and unvaccinated populations. The video also mentions the suppression of information and the manipulation of data by government agencies. The speaker urges viewers to stand up for their rights and the health of their children.

I'm an investigative reporter who initially trusted the medical establishment, but I've uncovered conflicts of interest and financial incentives that corrupt health research. The pharmaceutical industry legally launders taxpayer money through universities to produce unchallenged, biased studies. For example, a researcher who found a chemical feminizing frogs faced immense pressure to suppress his findings. Scientific journals are also compromised; former editors admit they couldn't stop industry-tainted studies. Drug companies ghostwrite articles for doctors to promote their products. They also influence medical schools, doctor education, media, and federal agencies, prioritizing profit over public health. This has led to a rise in chronic diseases, especially among children, that the medical establishment largely ignores. There's pressure to normalize these outcomes rather than address the root causes, as that is more profitable. Informed consent is also threatened, with the FDA loosening requirements for disclosing study risks.

A recent study claimed that the malaria drug Chloroquine does not inhibit SARS CoV 2. However, upon closer examination, it was found that the drug does work in kidney cells but not in lung cells. The study used a lung cancer cell line called KLU three, which led to the misunderstanding that Chloroquine allows the virus to attack cancer cells but not normal cells. This misinterpretation was deliberately hidden in the appendix of the study, contributing to a disinformation campaign. In reality, Chloroquine is a highly effective drug that can protect normal cells from the virus.

There was a recent FDA rejection of an MDMA-based therapy for PTSD, a program that had achieved, on its own terms, two successful phase three studies. The speaker notes that the trials were designed exactly as the FDA told them to design, but the episode is tied to the rise of advisory committees—FDA panels of so-called experts who opine on data and recommendations. The FDA is not bound by their recommendations, but they often follow them, sometimes not. In the speaker’s view, the FDA uses these advisory committees as a cover for what they actually want to do, a dynamic the speaker has observed across years in biotech as an investor and company builder. He has sat in eight-hour advisory committee sessions in Maryland, taking detailed notes, and while he didn’t attend the most recent one, he believes it smelled like the briefing documents provided to the committee were used to guide the outcome. He suspects the advisory committee recommended against approval, and the FDA then moved to that outcome. The speaker argues this is a travesty for PTSD patients who have very few options. He focuses on the reasoning the FDA gave for denying approval: the trial was functionally unblinded. Typically, trials use placebo and active drug arms with participants unaware of which treatment they receive, to ensure that observed effects are not merely placebo. The FDA claimed that patients knew whether they were on the MDMA-based therapy because some experienced euphoria, a side effect of the treatment. Therefore, the therapy could appear to work due to unblinding and a placebo effect, rather than a true therapeutic benefit. The speaker emphasizes that the possibility of euphoria being part of the drug’s mechanism—and thus related to its therapeutic effect—was ignored in their assessment, and that this unblinding was, in his view, anticipated by the FDA before agreeing to the phase three protocol, which also added tens or hundreds of millions of dollars in development costs. The speaker criticizes the public record, including biotech press coverage, for focusing on “trial irregularities” or an unblinding issue rather than on the broader cost-benefit and mechanistic considerations. He asserts that the public is left with the notion that there were unblinding issues, not recognizing that the unblinding related to the drug’s therapeutic properties was anticipated and approved by the FDA. He concludes that the episode reveals how the bureaucratic machinery operates, with advisory committees and briefing documents shaping outcomes in a way that aligns with the FDA’s underlying aims.

The speaker discusses the controversy surrounding statins, a widely prescribed cholesterol-lowering drug. They explain that the rise in statin prescriptions is due to changes in guidelines and industry influence. The speaker highlights concerns about industry bias in statin trials and the lack of transparency in sharing data on side effects. They also discuss how drug companies market statins by exaggerating benefits and silencing dissenting views. The speaker shares their own experience with a controversial TV program on statins and the backlash they faced. They conclude by emphasizing the importance of providing patients with honest and transparent information to make informed decisions about their medications.

In this video, the speaker discusses the Pfizer vaccine trial and raises concerns about the lack of long-term data. They mention that the trial was unblinded after only 2-4 months instead of the promised 5 years, which they consider deceptive. The speaker argues that without a longer placebo-controlled trial, potential long-term effects may be missed. They also highlight the number of deaths in both the vaccine and placebo groups, stating that the vaccine group had slightly fewer deaths from COVID-19 but more deaths from all causes. The speaker concludes that the vaccine may increase the risk of cardiac arrest. They express skepticism about recommending or mandating the vaccine based on the available data.

This video discusses the lack of safety studies and transparency surrounding vaccines. It highlights the conflicts of interest within government agencies and the pharmaceutical industry, as well as the limited research on the long-term effects of vaccines. The speaker emphasizes the need for a vaxxed versus unvaxxed study to determine the safety and effectiveness of vaccines. The video calls for greater accountability and transparency in the vaccine industry to protect the health and well-being of children. (147 words)

Despite it being treated as an obligation to do so, physicians reportedly do not know these facts. The speaker expresses strong frustration about the situation. The speaker cites a famous medical journal, the New England Journal of Medicine, describing a study of vaccine researchers and stating that “the 12.6 percent user rate” was reported, and that the paper claimed there was no problem with the vaccine based on that figure. Using that paper as a basis, the San Fujikawa Society or a similarly named organization promoted vaccination for pregnant women. However, the actual content of the data is described as follows: of 827 people, 700 were in the late stage of pregnancy, and 127 were in the early stage (first trimester). For the subgroup limited to those under 20 weeks’ gestation, i.e., the 127 individuals, the reported miscarriage rate was 82 percent. From this, the speaker argues that the vaccine is dangerous, given the result for the early-stage group. It is claimed that the data were hidden or obscured, and that the later report combined the late-pregnancy group of 700 with the early-pregnancy group of 127 to produce a 12.6 percent miscarriage rate, which was then published. The speaker concludes that even a major medical journal could be influenced by external financial pressures, resulting in biased reporting that supports the other side’s interests.

In this video, the speaker discusses the Pfizer vaccine trial and raises concerns about the lack of long-term data. They mention that the trial was unblinded after a short period of time, which they consider deceptive. The speaker also criticizes the way the vaccine's effectiveness is presented, stating that the number needed to vaccinate to save one life is 22,000. They highlight that more people died in the vaccine group compared to the placebo group, and that taking the vaccine increases the likelihood of dying from all causes and cardiac arrest. The speaker concludes by expressing their opposition to recommending or mandating the vaccine.

A recent study suggests that Pfizer may have excluded known deaths in the vaccine arm of its clinical trial from its data filing with the FDA in 2020. The study also found that trial subjects vaccinated with Pfizer's COVID-19 vaccine experienced a significant increase in cardiovascular deaths compared to placebo controls. This information was not disclosed by Pfizer when the FDA was evaluating the vaccine for emergency use. Additionally, researchers identified instances where Pfizer attributed potential vaccine-associated deaths to other causes, undermining vaccine safety data. The data presented to the FDA prior to the authorization of Pfizer's vaccine did not include all the deaths that occurred during the trial. The speaker raises concerns about the prioritization of profit over lives and warns against trusting Big Pharma.

The speaker claims there is active suppression of positive vitamin D news and research because it competes with top-selling drugs. The speaker presented data to top vitamin D researchers and faced vicious attacks, with researchers claiming vitamin D doesn't do what the data suggested. The speaker stated they were only presenting assembled data. The speaker was told they were jeopardizing careers of researchers who had spent their lives studying vitamin D, because they never conceived the presented data could be true.

The video discusses the controversy surrounding the antidepressant drug Seroxat (also known as paroxetine). It highlights concerns about the drug's safety, including its potential to cause suicidal thoughts, self-harm, and addiction. The Medicines Healthcare Products Regulatory Agency (MHRA), the regulatory body responsible for approving drugs, is criticized for failing to properly investigate and address these concerns. The video also reveals that GlaxoSmithKline, the manufacturer of Seroxat, knew about the drug's risks but did not disclose them. The lack of transparency and accountability in the regulatory system is seen as a wider issue that extends beyond Seroxat and raises questions about the safety of other prescription medications.

A recent study found that the malaria drug Chloroquine does not inhibit SARS CoV 2 in lung cells, although it may work in kidney cells. The speaker, who has experience in ocular oncology, contacted the author of the study and pointed out that the lung cells used in the study were actually cancer cells. This means that Chloroquine allows the virus to attack cancer cells but not normal cells. The speaker believes that this is a misinterpretation of the data and accuses the study of being part of a disinformation campaign. They argue that Chloroquine is actually a very effective drug.

Many drugs once deemed safe and effective have been removed from the market due to serious health risks. For example, Accutane was linked to liver damage after 27 years, and DES, initially used to prevent miscarriages, was found to cause them instead. Thalidomide, which caused severe birth defects, also raised concerns. The funding sources for studies are crucial, as industry grants often influence research outcomes. Universities and nonprofits may receive funding from these industries, leading to potential conflicts of interest. Additionally, medical journals rely on industry advertising, which can compromise their integrity. A significant issue is that companies can selectively publish data, omitting studies that do not support their claims. Ultimately, the field of science is lacking in ethics.

176 drugs that were considered safe and effective, but now are off the market because they found they were quite dangerous. Accutane, they took it off the market because they found it creates liver damage after twenty seven years. Hey, these things were backed by science. But I think the worst of the worst is that industry is allowed to cherry pick their data and not have to publish the studies that don't align with what they want. So the main question is who is funding the study, which many times gives grants to universities. And then you have industry, which then also funds the universities. And then we allow industry to pay certain individuals who sit on boards and committees that regulate a lot of the guidelines in our health care. Unfortunately, what we're missing in science is this thing called ethics.

The speaker believes COVID vaccine programs should be stopped. They are astounded by the number of papers critical of the vaccine or showing negative effects. The speaker claims a group of researchers funded by Pfizer and the NIH bullies editors to retract papers with negative findings about the vaccine. They assert the number of retractions is appalling. According to the speaker, in one instance where an editor resisted, Nature Springer bought the journal and retracted the paper. The speaker states that this is what they have been dealing with.